Hedge Funds case studies, worked step by step
- Cases
- 100
- Traced to a firm
- 31
- Topics
- 13
- Hard
- 30
Topic
All topicsCredit, distressed and capital structure7Earnings, models and KPIs8Event-driven and merger arbitrage7Fund economics, NAV and LP decisions8Global macro trades7Long pitches and valuation14Manager evaluation and attribution7Pairs and relative value5Portfolio construction and sizing7Risk limits and drawdowns7Short selling6Systematic research and data11Volatility, options and convertibles6
Showing 1–7 of 7 · filtered from 100Clear filters
- 007Pellora Long-Short Fund returned 9% in a year when the market returned 15%. Its average beta was 0.4 and cash earned 6%. Did it underperform?Fund of funds and allocatorsMulti-manager platforms
- 019Hillsan Credit Opportunities Fund reports annualised volatility of 4% with first-order autocorrelation of 0.5 in its monthly returns, because it marks illiquid loans to model. What is its likely true volatility, and what does that do to its Sharpe ratio?Fund of funds and allocatorsMulti-manager platforms
- 032The stock you pitched in a case competition, Selvora Chemicals, fell 22% in the six months after. The market fell 5%, the chemicals sector 8%, and Selvora's beta to the sector is 1.1. How much of the fall was your thesis, and how do you talk about it in an interview?Point72New York · 2026
- 057Ambeth Fund and Corlane Fund both returned 12% last year. Ambeth had 8% volatility and a beta of 0.2; Corlane had 15% volatility and a beta of 0.9. The market returned 10% and cash 6%. Which manager showed more skill?Fund of funds and allocatorsMulti-manager platforms
- 069The Rivanta pod beat its benchmark by 2%. It overweighted banks (30% against 20%) and underweighted IT (10% against 25%), with its own stock returns in each sector given. Split the excess return into allocation and selection effects.Fund of funds and allocatorsMulti-manager platforms
- 082An analyst at Tavish Capital made 40 trades: 18 winners averaging Rs 1.8 crore and 22 losers averaging Rs 1.0 crore. What is the hit rate, the expectancy per trade, and what would you tell the analyst?Fund of funds and allocatorsMulti-manager platforms
- 094Dhanvi Diagnostics grew revenue 30% a year for three years: 12 points organic and 18 points from acquisitions bought at 12x EBITDA with debt, while the stock trades at 25x. How much of shareholders' return came from M&A rather than the core business, and how would you judge the quality of that growth?Viking Global InvestorsNew York · 2025
Company names and figures are illustrative.
